| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.0061 | 0.8 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.0059 | 0.9 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | -0.0068 | 0.9 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.0068 | 0.9 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.0058 | 0.9 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.0062 | 0.9 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | -0.0063 | 0.9 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.0078 | 0.9 |